ArticlePDF Available

Pulsed Near Infrared Transcranial and Intranasal Photobiomodulation Significantly Modulates Neural Oscillations: a pilot exploratory study

Springer Nature
Scientific Reports
Authors:

Abstract and Figures

Transcranial photobiomodulation (tPBM) is the application of low levels of red or near-infrared (NIR) light to stimulate neural tissues. Here, we administer tPBM in the form of NIR light (810 nm wavelength) pulsed at 40 Hz to the default mode network (DMN), and examine its effects on human neural oscillations, in a randomized, sham-controlled, double-blinded trial. Using electroencephalography (EEG), we found that a single session of tPBM significantly increases the power of the higher oscillatory frequencies of alpha, beta and gamma and reduces the power of the slower frequencies of delta and theta in subjects in resting state. Furthermore, the analysis of network properties using inter-regional synchrony via weighted phase lag index (wPLI) and graph theory measures, indicate the effect of tPBM on the integration and segregation of brain networks. These changes were significantly different when compared to sham stimulation. Our preliminary findings demonstrate for the first time that tPBM can be used to non-invasively modulate neural oscillations, and encourage further confirmatory clinical investigations.
This content is subject to copyright. Terms and conditions apply.
1
SCIENTIFIC REPORTS | (2019) 9:6309 | https://doi.org/10.1038/s41598-019-42693-x
www.nature.com/scientificreports
Pulsed Near Infrared Transcranial
and Intranasal Photobiomodulation
Signicantly Modulates Neural
Oscillations: a pilot exploratory
study
Reza Zomorrodi1,2, Genane Loheswaran2, Abhiram Pushparaj3 & Lew Lim2
Transcranial photobiomodulation (tPBM) is the application of low levels of red or near-infrared (NIR)
light to stimulate neural tissues. Here, we administer tPBM in the form of NIR light (810 nm wavelength)
pulsed at 40 Hz to the default mode network (DMN), and examine its eects on human neural
oscillations, in a randomized, sham-controlled, double-blinded trial. Using electroencephalography
(EEG), we found that a single session of tPBM signicantly increases the power of the higher oscillatory
frequencies of alpha, beta and gamma and reduces the power of the slower frequencies of delta and
theta in subjects in resting state. Furthermore, the analysis of network properties using inter-regional
synchrony via weighted phase lag index (wPLI) and graph theory measures, indicate the eect of tPBM
on the integration and segregation of brain networks. These changes were signicantly dierent when
compared to sham stimulation. Our preliminary ndings demonstrate for the rst time that tPBM can
be used to non-invasively modulate neural oscillations, and encourage further conrmatory clinical
investigations.
Photobiomodulation (PBM) refers to the application of low levels of red or near-infrared (NIR) light to either
stimulate or inhibit biological cells and tissues involving photochemical mechanisms1. It was rst discovered in
1967 when Endre Mester observed that low powered laser treatment promoted hair regrowth and wound healing
in rats2,3. is inspired numerous investigations into the use of low level lasers and light emitting diodes (LEDs)
for therapeutic purposes, collectively termed ‘low level light therapy’ (LLLT). In 2015, a global initiative was taken
by researchers in this eld to standardize the term to ‘photobiomodulation’.
Transcranial PBM (tPBM), targeting delivery of light energy to the brain, is associated with increased cerebral
blood ow, oxygen availability and consumption, adenoside triphophosphate (ATP) production, and improved
mitochondrial activity4. More recently, tPBM has demonstrated its value as a treatment for neurological510 and
neurodegenerative conditions, including Alzheimer’s disease11,12.
us, tPBM is a form of non-invasive brain stimulation (NIBS). However, compared to the more established
forms of NIBS, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation
(tDCS), the concept of the brain being responsive to light stimulation is unfamiliar to many. In recent years,
research on the potential ecacy of tPBM has gained momentum13. Research on the eect of PBM on brain cell
recovery has shown that, under laboratory conditions, damaged neurons can regrow their neurites with direct
exposure to visible red low level lasers14. In an animal study, PBM has been found capable of promoting neuro-
genesis aer ischemic stroke through the proliferation and dierentiation of internal neuroprogenitor cells15.
e eect of PBM on mitochondrial function is the most well investigated mechanism of its potential thera-
peutic eects4. PBM has been demonstrated to increase the activity of complexes in the electron transport chain
of mitochondria, including complexes I, II, III, IV and succinate dehydrogenase16. In particular, increased activity
of the transmembrane protein complex IV, also known as the enzyme cytochrome c oxidase, during PBM results
1Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
2Vielight Inc., Toronto, Ontario, Canada. 3Ironstone Product Development Inc. & Qunuba Sciences Inc., Toronto, Ontario,
Canada. Correspondence and requests for materials should be addressed to R.Z. (email: Reza.Zomorrodi@camh.ca)
Received: 1 November 2018
Accepted: 5 April 2019
Published: xx xx xxxx
OPEN
Content courtesy of Springer Nature, terms of use apply. Rights reserved
2
SCIENTIFIC REPORTS | (2019) 9:6309 | https://doi.org/10.1038/s41598-019-42693-x
www.nature.com/scientificreports
www.nature.com/scientificreports/
in increased ATP production16. Furthermore, PBM results in activation of signaling pathways and transcription
factors resulting in increased expression of genes related to protein synthesis, cell migration and proliferation,
anti-inammatory signaling, anti-apoptotic protein and antioxidant enzymes4.
In a recent review of NIBS methods that included a comparison between tDCS, TMS and tPBM, Giordano et
al., recognized that the mechanisms of tPBM are better understood than tDCS but “there is little evidence to date
that (tPBM) produces direct neural activity”17. It is therefore timely that this study presents the eects of tPBM
in terms of electrophysiological measures of the brain using electroencephalography (EEG). Apart from the fun-
damental mitochondrial-based mechanism resulting from the delivery of NIR to brain tissues, there have been
indications that certain adjustable parameters may have an inuence on neural activities, particularly the pulsing
rate of the NIR delivery12,18,19. is double-blind, crossover study gives us the opportunity to analyze objective
data to understand the eect of a selected pulse frequency of 40 Hz and other PBM parameters on neural activity.
It may open up the possibility of exploring the eects of alternative PBM parameters in future studies.
Methods
Study Design. is was a small, exploratory, double-blind, prospective cross-over study. Study subjects
attended two study visits (Fig.1): one visit where the subjects received active tPBM stimulation with rest EEG and
another visit where the subjects received sham tPBM stimulation with rest EEG. e orders of the two visits were
randomized and there was a minimum one-week washout period between the two visits.
Study Visits. At the beginning of the rst study visit, each subject was screened for eligibility before proceeding
with enrollment. en the subject was asked to be seated in a comfortable chair and a 10 minute eyes closed EEG
recording was collected. Next, an active or sham tPBM device (described below) was positioned on the subject’s head
and turned on for 20 minutes. en the device was removed and another 10 minute eyes closed rest EEG was recorded.
Subjects. Twenty healthy adults (mean age 68.00 ± 5.94, 61–74 years of age, 9 Males) were recruited (Table1).
Written informed consent for participation in the study was obtained from all the subjects prior to enrollment
into the study. e study was conducted in compliance with the Declaration of Helsinki and was approved by the
research ethics board of IRB Services Canada. e individual included in Fig.2 and Supplementary Fig.2 has pro-
vided informed consent for publication of identifying information/images in an online open-access publication.
All data was anonymized and no subject identifying information or images are published. Subjects were excluded
if they had a Mini-Mental State Examination Score <27, a current major psychiatric or neurologic disease, a his-
tory of stroke, seizures and/or a medical condition uncontrolled with stable therapy. Subjects were compensated
for their participation at the end of the last study visit.
tPBM device. e tPBM device used in the study was the ‘Vielight Neuro Gamma’ (Neuro Gamma). It is a
portable, wearable, low-level light delivery device that administers near-infrared light to the brain transcranially
and intra-nasally. Its specications and intended use fall within the denition of a low risk general wellness device
in a policy guideline released by the Center for Devices and Radiological Health of the United States Food and
Drugs Administration in 2016, which exempts it from medical device regulations20. e device consists of a con-
troller, a nasal applicator, and a head set with four light emitting diode (LED) modules (Fig.2).
Figure 1. Schematic diagram of study design. Twenty healthy participants randomized to receive either active
or sham tPBM with a minimum 1-week washout period between the two visits. 10 minutes eye-closed rest EEG
recorded pre and post of each intervention.
Gender Sample Size (N) Age(years) Education(years)
Female 11 69 ± 6.32 12 ± 4.11
Male 9 66 ± 4.02 14 ± 3.71
Table 1. Demographic characteristics of the study population.
Content courtesy of Springer Nature, terms of use apply. Rights reserved
3
SCIENTIFIC REPORTS | (2019) 9:6309 | https://doi.org/10.1038/s41598-019-42693-x
www.nature.com/scientificreports
www.nature.com/scientificreports/
e Neuro Gamma delivers painless, non-invasive, non-thermal, non-laser, pulsed (40 Hz; 50% duty cycle),
near-infrared light (810 nm wavelength) through 5 non-laser LEDs over a 20- minute session. e device is pow-
ered by three rechargeable NiMH batteries. e LEDs have been designed to be positioned to deliver the near
infrared light (NIR) to the subdivisions of the default mode network (DMN)19. ese subdivisions include the
ventral medial prefrontal cortex (vmPFC); the dorsal medial prefrontal cortex (dmPFC); the posterior cingulate
cortex (PCC); adjacent precuneus (PCu) plus the lateral parietal cortex (LPC) and the entorhinal cortex (EC)19.
“Hubs” and “nodes” described in literature are synonymous with these subdivisions or are located within the
vicinity of these subdivisions. As shown in Fig.2, one of the Neuro Gamma LEDs is placed inside the nose for
intranasal transmission of NIR light to the ventral section of the brain which includes the vmPFC and the olfac-
tory bulb which has a direct activating projection to the EC and parahippocampal area21. e remaining 4 LEDs
on the headset are positioned over selected locations to direct NIR to the neocortical subdivisions of the DMN -
the dmPFC, PCu, and posterior PCC (NIR light directed through the le and right angular gyri). ese locations
correspond to FPz, Cz, T3 and T4 respectively, described under the 10–20 EEG montage.
e group of LEDs containing those positioned on the dmPFC and intranasally (Group A LEDs) pulse in
synchrony (in-phased) and the other group of LEDs on the PCu and le and right LPCs (Group 2 LEDs) also
pulse in synchrony (in-phased) within its group. Between Group A and Group B LEDs, the pulsing frequencies
are completely asynchronous (out-of-phase).e power density output of the nasal applicator is 25 mW/cm2,
anterior LED is 75 mW/cm2, and three posterior LEDs, 100 mW/cm2. Over the set-time of 20 minutes, the energy
dose to the brain (headset and intranasal applicator) equals to 240 J/cm2. Detailed specications and parameters
are set out in Table2.
The Neuro Gamma has been independently tested by TUV SUD Canada for Electrical Safety as well as
Emissions & Immunity for Multimedia Class B Equipment.
EEG acquisition. The EEG signals were recorded using the DISCOVERY 24E (Brainmaster Inc.) at
256 Hz sampling rate and a bandwidth of 0.43–80 Hz. e amplier was a low-noise DC-sensitive and a 24-bit
analog-to-digital device. For the EEG cap, we used a 19-Channel free-cap set (Institut für EEG-Neurofeedback),
which allows EEG to be recorded during tPBM delivery. e EEG channels located at a 10–20 montage on the
elastic net. e data was collected during the 10-minute sessions with the subjects at rest and with the eyes closed,
before and aer Neuro Gamma stimulation.
Figure 2. e Vielight Neuro Gamma in use. e stimulation modules consist of a Nasal Applicator, and a
Head Set with four light emitting diode (LED) modules intended to be positioned over the hubs of the default
mode network (DMN).
Source LED
Wavelength (nm) 810
Power output of LED on the anterior band (mW) 75(transcranial)
Power output of each LED on the posterior band (mW) 25(intranasal)
Power density of LED on the anterior band (mW/cm2) 100(transcranial)
Power density of each LED on the posterior band (mW/cm2) 25(intranasal)
Pulse frequency (Hz) 40
Pulse duty cycle, percentage 50
Duration of each treatment session (min) 20
Beam spot size (cm2)1
Total energy delivered per session (Joules) 240
Total energy density per session (Joules/cm2) 240
Table 2. Vielight Neuro Gamma Parameters.
Content courtesy of Springer Nature, terms of use apply. Rights reserved
4
SCIENTIFIC REPORTS | (2019) 9:6309 | https://doi.org/10.1038/s41598-019-42693-x
www.nature.com/scientificreports
www.nature.com/scientificreports/
EEG data preprocessing. EEG data was processed oine using a custom MATLAB script (MathWorks, MA,
USA), and EEGLAB toolbox (Swartz Center for Computational Neuroscience, University of California at San Diego)
in the following sequence. First, EEG data were visually inspected to remove noisy channels or highly contaminated
artifacts. ereaer, EEG data were digitally ltered by using a second order, Butterworth, zero-phase shi 1–55 Hz
band pass lter (24 dB/Oct), and then segmented into 2 sec epochs. en, an electrodes-by-trials matrix of ones was
created and assigned a value of zero if an epoch had: (1) amplitude larger than +/150 μV; (2) standard deviation
3 times larger than the average of all trials; or (3) power spectrums that violated 1/f power law. An electrode was
rejected if its corresponding row had more than 60% of columns (trials) coded as zeros. An epoch was removed if its
corresponding column had more than 20% of rows (electrodes) coded as zeros. An independent component analysis
(ICA) (EEGLAB toolbox; Infomax algorithm) was performed to remove ocular, muscle artifacts, and other noise
from the EEG data. Finally, the data was re-referenced to the average for further analysis.
EEG analysis of power, network connectivity and synchrony. e power spectrum analysis was con-
ducted using the spectopo () function as implemented in EEGLAB, using Welch’s method (with a window length of
512 points, () length of 1024 points, non-overlap). e absolute power was calculated for each channel and each
frequency band: Delta (1–3) Hz, eta (4–7) Hz, Alpha (8–14) Hz, Beta (14–30) Hz and Gamma (30–50) Hz.
To explore a possible change in brain functional connectivity and synchrony, we used the weighted phase lag
index (wPLI) and graph theory measure. e weighted phase lag index is a functional connectivity measure and
assesses the phase ‘lagging’ consistency between each pair of EEG channels. e advantages of wPLI over other
cerebral synchrony assessments are its lower sensitivity to noise and volume conduction eects, therefore provid-
ing more reliable evaluation of long range synchronization of neural activity22. e wPLI ranges between 0 (no
phase consistency) and 1 (full synchrony).
A network based on wPLI was constructed and graph measures were employed to evaluate network integra-
tion, segregation and quantifying eciency of information transfer23,24. Four graph measures were computed
using the Brain connectivity toolbox (BCT)25: (I) e characteristic path length (CPL), which is the average
length of all pairwise shortest paths connecting any node to another, to assess integration; (II) the clustering
coecient (CC), which is the mean nodal CC averaged across all vertices to assess segregation; (III) the global
network eciency, which quanties the exchange of information across the whole network; and (IV) the local
network eciency, which quanties a network’s resistance to failure on a small scale and characterizes how well
information is exchanged by its neighbors when a node is removed.
EEG channels and the value of wPLI represent nodes (i.e, 19) and edge (i.e., 19 × 19) of the network, respec-
tively. For each frequency band, we applied dierent sparsity thresholds by choosing 5–100% of the strongest
wPLI to binarize the edges. e sparsity-based threshold ensures the same number of edges for each network.
en, we evaluated the signicance of changes in the network properties before and aer active and sham stimu-
lations for dierent sparsity levels.
Statistical analyses. Dierences in power spectrum over all electrodes were statistically assessed using a
cluster-based permutation test that identies clusters of electrodes with signicant changes, while correcting
for multiple comparisons26. Cluster-level statistics were computed by taking the sum of the t-values over adja-
cent neighboring electrodes. Clusters were dened as two or more spatially contiguous electrodes in which the
t-statistics of power spectrum exceeded a chosen threshold of alpha level of p < 0.05 and αcluster = 0.01. e null
distribution was obtained by randomly permuting 1000 pieces of data (i.e., randomizing data across pre and post
tPBM and rerunning the statistical test). e Matlab toolbox Fieldtrip was used for this analysis13,27. To sum-
marize the data, we averaged the power of 19 EEG electrodes for each subject and ran two sided nonparametric
Wilcoxon tests to compare the ratio of post over pre-stimulation values of active and sham conditions.
At each level of network sparsity level, the brain network properties were compared using two sided nonpar-
ametric Wilcoxon paired-sample t-tests. e brain networks with dierent sparsity levels are considered inde-
pendent graphs, and thus the correction for multiple comparisons (e.g. Bonferroni correction) is not required24,25.
Results
Power spectrum analysis. Cluster-based permutation tests, with t-values presented by topological maps,
are reported in Fig.3 for comparison between pre- and post-tPBM sessions in both sham and active conditions.
In Fig.3, clusters of electrodes with power values that are signicantly dierent (p < 0.05 aer Bonferroni correc-
tion) between the two conditions are marked by a plus sign. Decreases or increases in absolute power are color
coded in dark blue and dark red, respectively.
Signicant absolute power spectrum alterations aer 20 minutes of active tPBM were observed in all oscilla-
tory frequency bands. Figure3a illustrates the pre- and post-stimulation dierences in power spectrum for active
tPBM. In the delta and theta frequency bands, there were signicant increases in power in the centro-frontal elec-
trodes (4 < t-values < 6, p < 0.05) but no signicant dierence in the temporal, parietal and occipital electrodes
(t = 0.156, p > 0.05). In the alpha, beta and gamma bands, we observed signicant increases (t-value > 7, p < 0.05)
in almost all of the electrodes. Twenty minutes of sham tPBM resulted in signicant changes in power spectrum,
but with non-specic locations and frequency signatures (5 < t-values < 6, p < 0.05) (Fig .3b). e comparison
between rest-EEG before (or pre) both active and sham conditions (1 week interval) showed no signicant dier-
ence across all electrodes (Fig.3c). However, the comparison between rest-EEG aer (or post-) active and sham
conditions revealed a distinct eect of active tPBM on the power spectrum. Our data showed: (I) decreases in
the lower oscillatory frequencies (i.e., delta and theta) with signicant reductions in the posterior region and, (II)
increases in higher oscillatory frequency bands with signicant alterations in centro-frontal regions for alpha and
beta, and a signicant global change in gamma power (t-value > 3, p < 0.05) (Fig.3d).
Content courtesy of Springer Nature, terms of use apply. Rights reserved
5
SCIENTIFIC REPORTS | (2019) 9:6309 | https://doi.org/10.1038/s41598-019-42693-x
www.nature.com/scientificreports
www.nature.com/scientificreports/
To evaluate the overall tPBM eects, we averaged the power spectrum across all electrodes for each oscillatory
frequency band and compared the ratio of post- over pre-session rest-EEG for both active and sham conditions.
Figure4 illustrates the boxplot of absolute power ratio. ere was an overall increase in power when comparing
post- to pre-stimulation in both the active (t = 6.855; p < 0.01; Fig.4a) and sham stimulation conditions (t = 6.996;
p < 0.01; Fig.4b). is increase was seen in all frequency bands for both sham (delta: t = 3.403, p < 0.01; theta:
t = 4.415, p < 0.01; alpha: t = 11.876, p < 0.01; beta: t = 10.756, p < 0.01; gamma: t = 10.876; p < 0.01; Fig.4b) and
active stimulation (delta: t = 6.177, p < 0.01; theta: t = 7.589, p < 0.01; alpha: t = 8.572, p < 0.01; beta: t = 9.553,
p < 0.01; gamma: t = 8.637; p < 0.01; Fig .4a). Interestingly, the change in power was frequency dependent during
active stimulation. In the active stimulation, there was a suppression in the increase in power of the delta and
theta bands that was observed during sham stimulation. Conversely, active stimulation produced a facilitation of
the increase in power in alpha, beta and gamma compared to sham.
A comparison between the active and sham groups presented signicant dierences in delta (t = 3.513
p < 0.01), theta (t = 3.736 p < 0.01), alpha (t = 4.455 p < 0.01), beta (t = 3.221 p < 0.01), and gamma (t = 2.658,
p < 00.1) frequency bands (Fig.4c).
Brain network functional connectivity and synchrony analyses. Brain network connectivity and
synchrony analyses in this study were based on the weighted phase lag index (wPLI) and graph measures to show
changes in the clustering coecient, characteristic path length (CPL) and local eciency measures. For each
frequency band and each sparsity level, mean and standard deviation of network indexes were plotted for both
active and sham tPBM conditions (Figs58).
e results of the functional network connectivity and synchrony analyses for dierent measures are as fol-
lows: For the active device, (I) e average cluster coecient (CC) showed signicant changes for a wide range
of sparsity levels: 45–80% sparsity levels in the alpha band, 35–55% and 65% sparsity levels in the gamma band,
75% in the theta band, and 80–85% in the beta band (Fig.5a). When the sham device was used (Fig.5b), the
average CC did not show signicant changes for most of the sparsity levels and frequency bands, apart from the
75%, 82% and 90% sparsity levels in the beta band. (II) e characteristic path length (CPL) showed a signicant
change only for active tPBM in the alpha band for 40–55% sparsity levels and in the gamma band for 50–55%
and 80–85% sparsity levels (Fig.6a). Sham treatments did not cause changes in the CPL for sparsity levels in any
frequency band (Fig.6b). (III) Aer active tPBM, local eciency of the network changed mostly in the alpha
band for 45–60% and 70–75% sparsity levels, in the gamma band for 40–50% sparsity levels, in the beta band for
80–85% sparsity levels, and in delta and theta bands for 85% and 80% sparsity levels, respectively (Fig.7a). In the
sham treatment condition, data showed alterations in local eciency in the beta band for 80% and 90% sparsity
levels and in the delta band at 80% (Fig.7b). (IV) Aer active tPBM treatments, the global eciency of the net-
work changed mostly in the alpha band for 50–60%, 75%, 85–90% sparsity levels, and in the gamma band for
15%, 50–60%, 70–75% and 90% sparsity levels (Fig.8a). e global eciency in sham condition did not change
in any frequency band (Fig.8b).
Figure 3. Non-parametric cluster-based permutation test comparing the rest EEG power spectrum between
active and sham tPBM. Topographical maps are color-coded according to the permutation tests t-values.
Clusters of electrodes with signicant dierence between the two conditions are marked in ‘+’ sign (p < 0.05
and αcluster = 0.01). (a) Dierence between post and pre active tPBM. (b) Dierence between post and pre sham
tPBM. (c) Dierence between pre active and sham tPMB. (d) Dierence between post active and sham tPMB.
Content courtesy of Springer Nature, terms of use apply. Rights reserved
6
SCIENTIFIC REPORTS | (2019) 9:6309 | https://doi.org/10.1038/s41598-019-42693-x
www.nature.com/scientificreports
www.nature.com/scientificreports/
Absence of Side Eects. roughout the study, none of the 20 participants self-reported any adverse events
or any unusual sensation.
Discussion
The ease-of-use of tPBM, along with its seemingly advantageous tolerability profile, make it an appealing
non-invasive brain stimulation (NIBS) method. To date, no published study has demonstrated the eect of tPBM
on neural activities and brain oscillations. In this cross-over, double-blind study, our results revealed a signicant
eect of transcranial near-infrared light (810 nm wavelength) at 40 Hz pulsing rate on the power, functional con-
nectivity and synchrony of endogenous brain activity.
Both the active and sham stimulations produced an increase in power in each of the frequency bands com-
pared to baseline. is increase in power in sham stimulation was unexpected and suggests that resting wake-
fulness increases cortical activation. Previous studies have demonstrated that subjective sleepiness following
prolonged periods of wakefulness (ie. 40 hours) have resulted in dierential changes in the power of various
frequency bands during the resting wakefulness state, measured with EEG28,29. However, to our knowledge, there
has been no report on the eects of 30 minutes of resting state on the power density spectrum in absolute values.
While a consistent increase in power was observed across all the frequency bands with both active and sham stim-
ulations, the change in power was frequency dependent with active stimulation. Compared to sham, active stimulation
presented suppression of the increase in the lower frequency bands (delta and theta) and a further increase in power
in the higher frequency bands (alpha, beta, and gamma). Interestingly, higher power in the lower frequency bands and
reduced power in the higher frequency bands have been associated with disorders involving cognitive impairment,
such as dementia and Alzheimer’s disease3034. e data observed from the use of the active tPBM device has produced
relevant results that are counter to the power spectrum characteristics of those conditions. erefore, this suggests that
active stimulation with 40 Hz NIR tPBM might be a desirable intervention to improve cognitive impairment, and could
potentially improve the cognitive function of patients with dementia and Alzheimer’s disease35,36.
e signicant alteration in the power spectrum and functional network properties in the alpha frequency
band could be due to the targeting of the default mode network (DMN) through its recognized hubs/subdi-
visions emphasized by EEG recording of subjects in resting wakefulness3740. e DMN is a network of brain
regions that are activated when the mind wanders without engaging in tasks such as attention or action, and it
is associated with introspection37,41, which are also largely characteristic of the brain in alpha state. Among all
DMN hubs, the medial prefrontal cortex (mPFC) plays a mechanistic role in the alpha generation process37,42.
Increased alpha power is posited to aid in the inhibition of irrelevant cortical areas while integrating relevant
ones, sharing another introspective characteristic in the function of the DMN4345. Additionally, spontaneous
self-referential thought is linked to the increase of alpha power in the posterior DMN (including the precuneus
and posterior cingulate) and gamma oscillations in the mPFC38,41,46,47. Several studies demonstrate deactivation of
DMN during task-related activities and its essential role in alternating between internal and external attention48.
Pathologies aecting the DMN include dementia, schizophrenia, autism, anxiety and depression42,49, suggesting
the importance of normalizing DMN functions. A way to achieve this could be through normalizing alpha fre-
quency oscillation.
Figure 4. Inuence of tPBM on resting-state electroencephalography. Box plot illustrates the median and range
of power spectrum across all electrodes for each oscillatory frequency bands. (a) Eect of active tPBM on power
spectrum pre (green line) and post (red line). (b) Eect of sham tPBM on power spectrum pre (green line) and
post (red line). (c) Dierence between Active and Sham tPBM: Change of power spectrum Post-Pre for active
(red line) and sham (green line) tPBM. Active versus sham stimulation revealed signicant lower alteration in
delta and theta power and higher change in alpha, beta and gamma frequency bands.
Content courtesy of Springer Nature, terms of use apply. Rights reserved
7
SCIENTIFIC REPORTS | (2019) 9:6309 | https://doi.org/10.1038/s41598-019-42693-x
www.nature.com/scientificreports
www.nature.com/scientificreports/
Figure 5. Connectivity assessment using Clustering coecient (CC). (a) Active tPBM caused index
signicantly changed CC for wide range of 45–80% sparsity levels in the alpha band, and 35–55% sparsity levels
in the gamma band. (b) Sham tPBM did not caused signicant change in CC index, but beta at 75, 82 and 90%
of sparsity levels. Blue and red lines line indicate pre and post conditions, respectively. e gray lines indicate a
signicant dierence (p < 0.01) at a certain sparsity level.
Figure 6. C onnectivity assessment using the characteristic path length (CPL). (a) Active tPBM caused index
signicantly changed CLP in the alpha band for 40–55% of sparsity levels and the gamma band for 50–55% and 80–85%.
(b) Sham tPBM did not cause any signicant change in CPL index. Blue and red lines line indicates pre and post
conditions, respectively. e gray lines indicate a signicant dierence (P < 0.01) at a certain sparsity level.
Content courtesy of Springer Nature, terms of use apply. Rights reserved
8
SCIENTIFIC REPORTS | (2019) 9:6309 | https://doi.org/10.1038/s41598-019-42693-x
www.nature.com/scientificreports
www.nature.com/scientificreports/
Figure 7. Connectivity assessment using Local Eciency measure. (a) Active tPBM caused signicant changes
in network local ecacy mostly in the alpha band for 45–60% and 70–75% of sparsity levels, in the gamma band
for 40–50% of sparsity levels, in the beta band for 80–85% of sparsity levels, and in delta and theta bands for 85%
and 80% of sparsity levels, respectively. (b) Sham tPBM did not cause any signicant change in the local ecacy
except in the beta band for 80 and 90% of sparsity levels. Blue and red lines line indicate pre and post conditions,
respectively. e gray lines indicate a signicant dierence (P < 0.01) at a certain sparsity level.
Figure 8. Connectivity assessment using Global Eciency measure. (a) Active tPBM caused signicant
changes in network global ecacy in the alpha band for 50–60%, 75%, 85–90% of sparsity levels, in the gamma
band for 15%, 50–60%, 70–75% and 90% of sparsity levels. (b) Sham tPBM did not cause any signicant change
in the global ecacy. Blue and red lines line indicate pre and post conditions, respectively. e gray lines
indicate a signicant dierence (P < 0.01) at a certain sparsity level.
Content courtesy of Springer Nature, terms of use apply. Rights reserved
9
SCIENTIFIC REPORTS | (2019) 9:6309 | https://doi.org/10.1038/s41598-019-42693-x
www.nature.com/scientificreports
www.nature.com/scientificreports/
Additionally, by analyzing brain network properties using wPLI and the graph theory measures, we observed
signicant eects of active tPBM. e connectivity measures, which assessed the integration and segregation
properties of the network, showed a signicance increase in clustering coecient, characteristic path length
(CPL) and local eciency measures for each oscillation frequency band. e changes were most prominently in
the alpha frequency bands. e increased connectivity and synchrony achieved by inducing 40 Hz to the DMN
is novel. It warrants new investigations on how this could help with conditions that have characteristically low
connectivity and synchrony in fast frequency bands.
A recent study by Chao and colleagues also demonstrated the impact of tPBM on DMN connectivity, specically
increased connectivity in the posterior cingulate cortex and lateral parietal lobes, using functional magnetic res-
onance imaging (fMRI). is increase in connectivity was correlated with improved cognition in patients with
dementia50.
e pulse frequency employed likely plays an important role in the eects of tPBM on brain activity. Pulsing
NIR light not only minimizes the heating eect and increases the possible penetration depth51,52, but may eec-
tively interact with cellular activity via two proposed mechanisms by: (a) impacting the ionic channels kinetic
such as potassium and calcium in the mitochondria16,51,53 (b) increasing the dissociation rate of nitric oxide from
cyctochrome c oxidase9,16,54. A study by Iaccarino et al. has demonstrated that the visual processing of 40 Hz
pulsing light signicantly reduces β-amyloid deposits in the visual cortex of an AD animal model, similar to
that observed from optogenetic “gamma entrainment” of fast-spiking parvalbumin-positive interneurons19. is
nding further suggests that the 40 Hz pulsing of NIR tPBM should be further explored to address AD pathology.
We hypothesize that the action of 40 Hz NIR tPBM results in increased organization of neural function, which
is likely to be accompanied by an increase in inhibition. During cognitive processes such as memory consolida-
tion, the presence of gamma oscillations prevents neurotoxicity55. e amplitude of gamma oscillations is associ-
ated with GABA levels, with increased levels of GABA being correlated to an increased amplitude of the gamma
band56. Future studies are required to conrm the eect of 40 Hz NIR tPBM on GABA levels.
ere are several established theories for the ability of PBM to act locally and systemically; however, to our
knowledge, this is the rst study demonstrating an eect at the network level, through the observed changes in
brain oscillations. is network eect may be mediated by increased intracellular Ca2+ concentration which has
been observed at certain PBM doses57,58 potentially occurring through the engagement of the voltage-gated cal-
cium channels59. Animal experiments have produced evidence of signicant increases in the membrane potential
with Ca2+ potentially underlying gamma oscillations of around 40 Hz60,61.
Together, these ndings present the potential of tPBM as a valuable form of NIBS, oering a safe experi-
mental tool to interact with the brain. PBM has minimal reported adverse eects, provided the parameters are
understood at least at a basic level62. e potential of a tPBM device to signicantly modulate the brain opens
new opportunities for its use in research and therapeutic settings. is study presents for the rst time, the sig-
nicant modulatory eect tPBM has on the brain oscillatory patterns as measured with EEG. e main mod-
ulating parameters in the device used in the study are likely to be the 810 nm wavelength and the pulse rate of
40 Hz. Delivering these parameters to the hubs/subdivisions of the default mode network this way, signicantly
increased the power of the high oscillatory frequencies of alpha, beta and gamma; and reduced the power of the
slower frequencies of delta and theta. ese have been achieved aer each single session of active treatment with
the subjects in resting wakefulness state. In addition, the brain presented global inhibition, indicating increased
organization.
Some important indications have been achieved in this study: (I) Despite not being obvious and no experience
of sensation by the subject, NIR light delivered with relatively low power density can draw response from the
brain that are measurable with EEG. (II) e signicant eects of tPBM when applied as presented in this study.
ese promising preliminary results present a considerable forward step leading to the need of a larger conrm-
atory clinical investigation, which could establish the role of tPBM as an eective non-invasive neuromodulatory
tool.
e potential capacity of tPBM to induce brain wave entrainment provides the opportunity to explore the
eect of varying selected parameters, such as the pulse frequencies, location of the LED modules, power out-
put, and pulse coherency between selected LEDs. For example, we could investigate the eect of two selected
LED locations to pulse in-phase (to increase coherency/synchrony) or out-of-phase (to reduce coherency/syn-
chrony). We could also investigate the dierences in outcomes of pulse synchrony between brain networks or
compare them with whole-brain synchrony. Answers to these investigations could potentially provide customized
approaches to the modulation of brain wave patterns. e relatively quick brain response suggests that tPBM is
a good candidate for use with neurofeedback methodologies, in order to optimize parameters for specic con-
ditions. Medical conditions such as Alzheimer’s disease which express low power and synchrony in the alpha,
beta and gamma and high power and synchrony in delta and theta brainwaves are obvious targets of future tPBM
research. e adjustability of the various parameters of tPBM, along with the relatively quick response observed
by EEG, is optimal for the exploration of customized treatments for varying indications.
References
1. Hamblin, M. . Photobiomodulation or low-level laser therapy. J Biophotonics 9, 1122–1124, https://doi.org/10.1002/jbio.201670113
(2016).
2. Mester, E., Ludany, G., Sellyei, M. & Szende, B. On the biologic eect of laser rays. Bull Soc Int Chir 27, 68–73 (1968).
3. Mester, E., Szende, B. & Gartner, P. e eect of laser beams on the growth of hair in mice. Radiobiol Radiother (Berl) 9, 621–626
(1968).
4. Hamblin, M. . Shining light on the head: Photobiomodulation for brain disorders. BBA Clin 6, 113–124, https://doi.org/10.1016/j.
bbacli.2016.09.002 (2016).
5. Detaboada, L. et al. Transcranial application of low-energy laser irradiation improves neurological decits in rats following acute
stroe. Lasers Surg Med 38, 70–73, https://doi.org/10.1002/lsm.20256 (2006).
Content courtesy of Springer Nature, terms of use apply. Rights reserved
10
SCIENTIFIC REPORTS | (2019) 9:6309 | https://doi.org/10.1038/s41598-019-42693-x
www.nature.com/scientificreports
www.nature.com/scientificreports/
6. Oron, A. et al. Low-level laser therapy applied transcranially to rats aer induction of stroe signicantly reduces long-term
neurological decits. Stroke 37, 2620–2624, https://doi.org/10.1161/01.ST.0000242775.14642.b8 (2006).
7. Oron, A. et al. Near infrared transcranial laser therapy applied at various modes to mice following traumatic brain injury signicantly
reduces long-term neurological decits. J Neurotrauma 29, 401–407, https://doi.org/10.1089/neu.2011.2062 (2012).
8. Lampl, Y. Laser treatment for stroe. Expert Rev Neurother 7, 961–965, https://doi.org/10.1586/14737175.7.8.961 (2007).
9. Hashmi, J. T. et al. ole of low-level laser therapy in neurorehabilitation. PM R 2, S292–305, https://doi.org/10.1016/j.
pmrj.2010.10.013 (2010).
10. Naeser, M. A., Saltmarche, A., rengel, M. H., Hamblin, M. . & night, J. A. Improved cognitive function aer transcranial, light-
emitting diode treatments in chronic, traumatic brain injury: two case reports. Photomed Laser Surg 29, 351–358, https://doi.
org/10.1089/pho.2010.2814 (2011).
11. Sommer, A. P. et al. 670 nm laser light and EGCG complementarily reduce amyloid-beta aggregates in human neuroblastoma cells:
basis for treatment of Alzheimer’s disease? Photomed Laser Surg 30, 54–60, https://doi.org/10.1089/pho.2011.3073 (2012).
12. Saltmarche, A. E., Naeser, M. A., Ho, . F., Hamblin, M. . & Lim, L. Signicant Improvement in Cognition in Mild to Moderately
Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series eport. Photomed Laser Surg 35,
432–441, https://doi.org/10.1089/pho.2016.4227 (2017).
13. Salehpour, F. et al. Brain Photobiomodulation erapy: a Narrative eview. Mol Neurobiol 55, 6601–6636, https://doi.org/10.1007/
s12035-017-0852-4 (2018).
14. Giuliani, A. et al. Low infra red laser light irradiation on cultured neural cells: eects on mitochondria and cell viability aer
oxidative stress. BMC Complement Altern Med 9, 8, https://doi.org/10.1186/1472-6882-9-8 (2009).
15. Yang, L. et al. Photobiomodulation therapy promotes neurogenesis by improving post-stroe local microenvironment and
stimulating neuroprogenitor cells. Exp Neurol 299, 86–96, https://doi.org/10.1016/j.expneurol.2017.10.013 (2018).
16. de Freitas, L. F. & Hamblin, M. . Proposed Mechanisms of Photobiomodulation or Low-Level Light erapy. IEEE J Sel Top
Quantum Electron 22, https://doi.org/10.1109/JSTQE.2016.2561201 (2016).
17. Giordano, J. et al. Mechanisms and Eects of Transcranial Direct Current Stimulation. Dose Response 15, 1559325816685467,
https://doi.org/10.1177/1559325816685467 (2017).
18. Ando, T. et al. Comparison of therapeutic eects between pulsed and continuous wave 810-nm wavelength laser irradiation for
traumatic brain injury in mice. PLoS One 6, e26212, https://doi.org/10.1371/journal.pone.0026212 (2011).
19. Iaccarino, H. F. et al. Gamma frequency entrainment attenuates amyloid load and modies microglia. Nature 540, 230–235, https://
doi.org/10.1038/nature20587 (2016).
20. Health, C. f. D. a. . Device Regulation and Guidance, https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/
guidancedocuments/ucm429674.pdf) (2016).
21. Biella, G. & de Curtis, M. Olfactory inputs activate the medial entorhinal cortex via the hippocampus. J Neurophysiol 83, 1924–1931,
https://doi.org/10.1152/jn.2000.83.4.1924 (2000).
22. Ortiz, E. et al. Weighted phase lag index and graph analysis: preliminary investigation of functional connectivity during resting state
in children. Comput Math Methods Med 2012, 186353, https://doi.org/10.1155/2012/186353 (2012).
23. Peters, J. M. et al. Brain functional networs in syndromic and non-syndromic autism: a graph theoretical study of EEG connectivity.
BMC Med 11, 54, https://doi.org/10.1186/1741-7015-11-54 (2013).
24. Stam, C. J., Jones, B. F., Nolte, G., Breaspear, M. & Scheltens, P. Small-world networs and functional connectivity in Alzheimer’s
disease. Cereb Cortex 17, 92–99, https://doi.org/10.1093/cercor/bhj127 (2007).
25. ubinov, M. & Sporns, O. Complex networ measures of brain connectivity: uses and interpretations. Neuroimage 52, 1059–1069,
https://doi.org/10.1016/j.neuroimage.2009.10.003 (2010).
26. Maris, E. & Oostenveld, . Nonparametric statistical testing of EEG- and MEG-data. J Neurosci Methods 164, 177–190, https://doi.
org/10.1016/j.jneumeth.2007.03.024 (2007).
27. Oostenveld, ., Fries, P., Maris, E. & Schoelen, J. M. FieldTrip: Open source soware for advanced analysis of MEG, EEG, and
invasive electrophysiological data. Comput Intell Neurosci 2011, 156869, https://doi.org/10.1155/2011/156869 (2011).
28. Strijstra, A. M., Beersma, D. G., Drayer, B., Halbesma, N. & Daan, S. Subjective sleepiness correlates negatively with global alpha
(8–12 Hz) and positively with central frontal theta (4–8 Hz) frequencies in the human resting awae electroencephalogram. Neurosci
Lett 340, 17–20, S0304394003000338 (2003).
29. Dij, D. J. et al. Melatonin eect on daytime sleep in men: suppression of EEG low frequency activity and enhancement of spindle
frequency activity. Neurosci Lett 201, 13–16, doi:030439409512118N (1995).
30. Brenner, . P. et al. Computerized EEG spectral analysis in elderly normal, demented and depressed subjects. Electroencephalogr
Clin Neurophysiol 64, 483–492, doi:0013-4694(86)90184-7 (1986).
31. Coben, L. A., Danziger, W. L. & Berg, L. Frequency analysis of the resting awae EEG in mild senile dementia of Alzheimer type.
Electroencephalogr Clin Neurophysiol 55, 372–380, doi:0013-4694(83)90124-4 (1983).
32. Coben, L. A., Danziger, W. & Storandt, M. A longitudinal EEG study of mild senile dementia of Alzheimer type: changes at 1 year
and at 2.5 years. Electroencephalogr Clin Neurophysiol 61, 101–112, doi:0013-4694(85)91048-X (1985).
33. Huang, C. e t al. Discrimination of Alzheimer’s disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional
and longitudinal study. Clin Neurophysiol 111, 1961–1967, doi:S1388245700004545 (2000).
34. Babiloni, C. et al. Mapping distributed sources of cortical rhythms in mild Alzheimer’s disease. A multicentric EEG study.
Neuroimage 22, 57–67, https://doi.org/10.1016/j.neuroimage.2003.09.028S1053811903005743 (2004).
35. Vielight Neuro Rx Gamma- Feasibility Pilot, https://clinicaltrials.gov/ct2/show/NCT03328195?term=Vielight&recrs=ab&ran=1
(2018).
36. Neuro RX Gamma - Pivotal Phase, https://clinicaltrials.gov/ct2/show/NCT03484143 (2018).
37. B onnard, M. et al. esting state brain dynamics and its transients: a combined TMS-EEG study. Sci Rep 6, 31220, https://doi.
org/10.1038/srep31220 (2016).
38. Chen, A. C., Feng, W., Zhao, H., Yin, Y. & Wang, P. EEG default mode networ in the human brain: spectral regional eld powers.
Neuroimage 41, 561–574, https://doi.org/10.1016/j.neuroimage.2007.12.064 (2008).
39. nyazev, G. G., Slobodsoj-Plusnin, J. Y., Bocharov, A. V. & Pylova, L. V. e default mode networ and EEG alpha oscillations: an
independent component analysis. Brain Res 1402, 67–79, https://doi.org/10.1016/j.brainres.2011.05.052 (2011).
40. Neuner, I. et al. e default mode networ and EEG regional spectral power: a simultaneous fMI-EEG study. PLoS One 9, e88214,
https://doi.org/10.1371/journal.pone.0088214 (2014).
41. Mantini, D., Perrucci, M. G., Del Gratta, C., omani, G. L. & Corbetta, M. Electrophysiological signatures of resting state networs
in the human brain. Proc Natl Acad Sci USA 104, 13170–13175, https://doi.org/10.1073/pnas.0700668104 (2007).
42. Bowman, A. D. et al. elationship Between Alpha hythm and the Default Mode Networ: An EEG-fMI Study. J Clin Neurophysiol
34, 527–533, https://doi.org/10.1097/WNP.0000000000000411 (2017).
43. Deco, G., Jirsa, V. . & McIntosh, A. . Emerging concepts for the dynamical organization of resting-state activity in the brain. Nat
Rev Neurosci 12, 43–56, https://doi.org/10.1038/nrn2961 (2011).
44. ut, G., Nietzel, A., Brandt, S. A. & Pascual-Leone, A. Alpha-band electroencephalographic activity over occipital cortex indexes
visuospatial attention bias and predicts visual target detection. J Neurosci 26, 9494–9502, https://doi.org/10.1523/
JNEUOSCI.0875-06.2006 (2006).
Content courtesy of Springer Nature, terms of use apply. Rights reserved
11
SCIENTIFIC REPORTS | (2019) 9:6309 | https://doi.org/10.1038/s41598-019-42693-x
www.nature.com/scientificreports
www.nature.com/scientificreports/
45. Jensen, O. & Mazaheri, A. Shaping functional architecture by oscillatory alpha activity: gating by inhibition. Front Hum Neurosci 4,
186, https://doi.org/10.3389/fnhum.2010.00186 (2010).
46. Voyte, B. et al. Shis in gamma phase-amplitude coupling frequency from theta to alpha over posterior cortex during visual tass.
Front Hum Neurosci 4, 191, https://doi.org/10.3389/fnhum.2010.00191 (2010).
47. Berovich-Ohana, A., Glicsohn, J. & Goldstein, A. Mindfulness-induced changes in gamma band activity - implications for the
default mode networ, self-reference and attention. Clin Neurophysiol 123, 700–710, https://doi.org/10.1016/j.clinph.2011.07.048
(2012).
48. Singh, . D. & Fawcett, I. P. Transient and linearly graded deactivation of the human default-mode networ by a visual detection
tas. Neuroimage 41, 100–112, https://doi.org/10.1016/j.neuroimage.2008.01.051 (2008).
49. Broyd, S. J. et al. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav Rev 33, 279–296,
https://doi.org/10.1016/j.neubiorev.2008.09.002 (2009).
50. Chao, L. (in press) Eects of home photobiomodulation treatments on cognitive and behavioral function, cerebral perfusion, and
resting-state functional connectivity in patients with dementia: A pilot trial. Photobiomodulation, Photomedicine, and Laser Surgery
(2019).
51. Hashmi, J. T. et al. Eect of pulsing in low-level light therapy. Lasers Surg Med 42, 450–466, https://doi.org/10.1002/lsm.20950
(2010).
52. Ilic, S. et al. Eects of power densities, continuous and pulse frequencies, and number of sessions of low-level laser therapy on intact
rat brain. Photomed Laser Surg 24, 458–466, https://doi.org/10.1089/pho.2006.24.458 (2006).
53. aru, T. I., Pyatibrat, L. V. & Afanasyeva, N. I. A novel mitochondrial signaling pathway activated by visible-to-near infrared
radiation. Photochem Photobiol 80, 366–372, https://doi.org/10.1562/2004-03-25-A-123 (2004).
54. Lane, N. Cell biology: p ower games. Nature 443, 901–903, https://doi.org/10.1038/443901a (2006).
55. Gan, J., Weng, S. M., Pernia-Andrade, A. J., Csicsvari, J. & Jonas, P. Phase-Loced Inhibition, but Not Excitation, Underlies
Hippocampal ipple Oscillations in Awae Mice In Vi vo. Neuron 93, 308–314, https://doi.org/10.1016/j.neuron.2016.12.018 (2017).
56. Chen, C. M. et al. GABA level, gamma oscillation, and woring memory performance in schizophrenia. Neuroimage Clin 4,
531–539, https://doi.org/10.1016/j.nicl.2014.03.007 (2014).
57. Sharma, S. . et al. Dose response eects of 810 nm laser light on mouse primary cortical neurons. Lasers Surg Med 43, 851–859,
https://doi.org/10.1002/lsm.21100 (2011).
58. Wang, L., Hu, L., Grygorczy, ., Shen, X. & Schwarz, W. Modulation of extracellular ATP content of mast cells and DG neurons
by irradiation: studies on underlying mechanism of low-level-laser therapy. Mediators Inflamm 2015, 630361, https://doi.
org/10.1155/2015/630361 (2015).
59. Jones, E. G. Calcium channels in higher-level brain function. Proc Natl Acad Sci USA 104, 17903–17904, https://doi.org/10.1073/
pnas.0709509104 (2007).
60. Llinas, ., ibary, U., Contreras, D. & Pedroarena, C. e neuronal basis for consciousness. Philos Trans R Soc Lond B Biol Sci 353,
1841–1849, https://doi.org/10.1098/rstb.1998.0336 (1998).
61. Singer, W. Consciousness and the structure of neuronal representations. Philos Trans R Soc Lond B Biol Sci 353, 1829–1840, https://
doi.org/10.1098/rstb.1998.0335 (1998).
62. Hamblin, M. . Mechanisms and applications of the anti-inammatory eects of photobiomodulation. AIMS Biophys 4, 337–361,
https://doi.org/10.3934/biophy.2017.3.337 (2017).
Author Contributions
R.Z., G.L., A.P. and L.L. designed the experiments. R.Z. and G.L. collected and analyzed the data. L.L. determined
the parameters of the device. R.Z., G.L., and L.L. wrote the paper. All authors discussed the results and
implications and commented on the manuscript at all stages.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-019-42693-x.
Competing Interests: Reza Zomorrodi and Abhi Pushparaj were advisors to the device manufacturer, Vielight
Inc., and were compensated for their time. ey had no other competing or conict of interest, nancial and
non-nancial. Genane Loheswaran is an employee of Vielight Inc. as the Research Manager and Lew Lim is the
Founder & Chief Executive Ocer who owns shares in Vielight Inc., and both have no other competing interest.
All the authors declare that these interests had no inuence on the results and discussion in the study.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and
institutional aliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. e images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
© e Author(s) 2019
Content courtesy of Springer Nature, terms of use apply. Rights reserved
1.
2.
3.
4.
5.
6.
Terms and Conditions
Springer Nature journal content, brought to you courtesy of Springer Nature Customer Service Center GmbH (“Springer Nature”).
Springer Nature supports a reasonable amount of sharing of research papers by authors, subscribers and authorised users (“Users”), for small-
scale personal, non-commercial use provided that all copyright, trade and service marks and other proprietary notices are maintained. By
accessing, sharing, receiving or otherwise using the Springer Nature journal content you agree to these terms of use (“Terms”). For these
purposes, Springer Nature considers academic use (by researchers and students) to be non-commercial.
These Terms are supplementary and will apply in addition to any applicable website terms and conditions, a relevant site licence or a personal
subscription. These Terms will prevail over any conflict or ambiguity with regards to the relevant terms, a site licence or a personal subscription
(to the extent of the conflict or ambiguity only). For Creative Commons-licensed articles, the terms of the Creative Commons license used will
apply.
We collect and use personal data to provide access to the Springer Nature journal content. We may also use these personal data internally within
ResearchGate and Springer Nature and as agreed share it, in an anonymised way, for purposes of tracking, analysis and reporting. We will not
otherwise disclose your personal data outside the ResearchGate or the Springer Nature group of companies unless we have your permission as
detailed in the Privacy Policy.
While Users may use the Springer Nature journal content for small scale, personal non-commercial use, it is important to note that Users may
not:
use such content for the purpose of providing other users with access on a regular or large scale basis or as a means to circumvent access
control;
use such content where to do so would be considered a criminal or statutory offence in any jurisdiction, or gives rise to civil liability, or is
otherwise unlawful;
falsely or misleadingly imply or suggest endorsement, approval , sponsorship, or association unless explicitly agreed to by Springer Nature in
writing;
use bots or other automated methods to access the content or redirect messages
override any security feature or exclusionary protocol; or
share the content in order to create substitute for Springer Nature products or services or a systematic database of Springer Nature journal
content.
In line with the restriction against commercial use, Springer Nature does not permit the creation of a product or service that creates revenue,
royalties, rent or income from our content or its inclusion as part of a paid for service or for other commercial gain. Springer Nature journal
content cannot be used for inter-library loans and librarians may not upload Springer Nature journal content on a large scale into their, or any
other, institutional repository.
These terms of use are reviewed regularly and may be amended at any time. Springer Nature is not obligated to publish any information or
content on this website and may remove it or features or functionality at our sole discretion, at any time with or without notice. Springer Nature
may revoke this licence to you at any time and remove access to any copies of the Springer Nature journal content which have been saved.
To the fullest extent permitted by law, Springer Nature makes no warranties, representations or guarantees to Users, either express or implied
with respect to the Springer nature journal content and all parties disclaim and waive any implied warranties or warranties imposed by law,
including merchantability or fitness for any particular purpose.
Please note that these rights do not automatically extend to content, data or other material published by Springer Nature that may be licensed
from third parties.
If you would like to use or distribute our Springer Nature journal content to a wider audience or on a regular basis or in any other manner not
expressly permitted by these Terms, please contact Springer Nature at
onlineservice@springernature.com

Supplementary resource (1)

... Research indicates that tPBM is linked to improvements in emotional well-being [18], enhanced executive functions [19], better attentional performance [18,20], improved prefrontal rule-based learning [21], and strengthened short-term memory [22]. Moreover, EEG analyses suggest that tPBM can modulate neural oscillations and brainwaves [23,24]. With these promising findings, researchers have begun to explore the underlying mechanisms and optimal parameters, such as wavelength, power density, fluence, and operational mode, to maximize tPBM's effects on high-level cortical functions. ...
... Previous research has suggested the possibility of resonance effects between light pulses and brainwaves at specific frequencies, such as 40 and 100 Hz [1,23,37]. However, the lack of significant differences between these groups in earlier studies indicates that frequency alone may not be the primary driver of PW tPBM effects. ...
Article
Full-text available
Background Transcranial photobiomodulation (tPBM) enhances cognitive and emotional states. We compared continuous‐wave (CW) and pulsed‐wave (PW) tPBM effects on 24 healthy males. Method Participants received 630 nm tPBM at 95 mW/cm ² for 10 min: Sham, CW, or PW (500 Hz). Outcomes were assessed using the Karolinska Sleepiness Scale (KSS) (for measuring sleepiness), State‐Trait Anxiety Inventory (STAI) (for assessing anxiety), Visual Analog Scale (VAS) (for measuring stress), and Beck Depression Inventory‐II (BDI‐II) (for evaluating depressive symptoms), and 32‐channel EEG at baseline, treatment, and rest phases. Results Paired t ‐tests showed PW tPBM significantly improved sleepiness, anxiety, stress, and depression scores post‐intervention ( p < 0.05). ANOVA analyses indicated PW tPBM increased Alpha and Gamma band EEG power versus baseline ( p < 0.05). Conclusion PW tPBM may improve cognitive and emotional outcomes and modulate brain activity, offering therapeutic insights.
... The relevance of PW-PBM is highlighted by the results yielded in a randomized, sham-controlled, double-blinded trial conducted in healthy subjects (41). A single session of NIR PW-PBM at 40 Hz, an average frequency corresponding to behaviorally-driven gamma brain oscillations, significantly increased the power of the higher oscillatory alpha, beta, and gamma frequencies, while reducing the power of the slower delta and theta frequencies in resting subjects. ...
... A single session of NIR PW-PBM at 40 Hz, an average frequency corresponding to behaviorally-driven gamma brain oscillations, significantly increased the power of the higher oscillatory alpha, beta, and gamma frequencies, while reducing the power of the slower delta and theta frequencies in resting subjects. Network property analysis revealed that transcranial PW-PBM acted on the integration and segregation of brain networks (41). These observations indicate that PW-PBM can be used to noninvasively modulate neuronal oscillations in humans, paving the way to further clinical investigations. ...
Article
Signaling molecules exhibit mechanical oscillations, entailing precise vibrational directionalities. These steering signatures have profound functional implications and are intimately connected with the onset of molecular electric oscillations and biophoton emission. We discuss biophotonic activity as a form of endogenous photobiomodulation, orchestrating the mechano-sensing/-transduction in signaling players. We focus on exogenous photobiomodulation in the form of pulsed wave modulation of selected light wavelengths to direct endogenous biophotonic activity and molecular cellular dynamics. We highlight the relevance of this strategy to target and reprogram the developmental potential of tissue-resident stem cells in damaged tissues, affording precision regenerative medicine without the need for cell or tissue transplantation.
... Sophia A Bibb novel method of brain stimulation, known as transcranial photobiomodulation (tPBM), may help to address these shortcomings. Transcranial photobiomodulation involves the use of light from the visible and near infrared (NIR) spectrum at a low power density on soft tissue for therapeutic effect (Cardoso et al., 2022;Fekri et al., 2019;Zomorrodi et al., 2019). In the context of neuromodulation, tPBM is applied to the scalp and penetrates through the bone up to ∼4 cm below the cortical surface (Tedford et al., 2015), which is deeper than TMS is able to penetrate, even when using the largest TMS coils available (Deng et al., 2013). ...
Article
Full-text available
No prior work has directly compared the impacts of transcranial photobiomodulation (tPBM) and transcranial magnetic stimulation (TMS) on the human brain. This within-subjects pilot study compares the effects of tPBM and TMS of human somatomotor cortex on brain structural and functional connectivity. Eight healthy participants underwent four lab visits each, each visit consisting of a pre-stimulation MRI, stimulation or sham, and a post-stimulation MRI, respectively. Stimulation and sham sessions were counterbalanced across subjects. Collected measures included structural MRI data, functional MRI data from a finger-tapping task, resting state functional connectivity, and structural connectivity. Analyses indicated increased activation of the left somatomotor region during a right-hand finger-tapping task following both tPBM and TMS. Additionally, trending increases in left-lateralized functional and structural connectivity from M1 to thalamus were observed after tPBM, but not TMS. Thus, tPBM may be superior to TMS at inducing changes in connected nodes in the somatomotor cortex, although further research is warranted to explore the potential therapeutic benefits and clinical utility of tPBM.
... Studies have shown that transcranial PBM can significantly influence brain activity, particularly in the prefrontal cortex, as evidenced by changes in EEG patterns [60]. When applied during wakefulness, PBM induces considerable alterations in resting power spectrum of different brain waves, with observed increases in α, β, and γ waves, suggesting its capacity to influence neural oscillations critical for sleep regulation [61]. Additionally, PBM has been demonstrated to enhance cerebral blood flow through NO-dependent vasodilation, potentially improving tissue oxygenation and metabolic function in sleep-relevant brain regions [62]. ...
Article
Full-text available
Photobiomodulation (PBM) is a non-invasive therapeutic technique employing specific wavelengths of red and near-infrared light to induce photochemical reactions in biological tissues without generating significant heat. PBM operates at low power densities, primarily acting through mitochondrial chromophores like cytochrome c oxidase to enhance cellular metabolism, energy production, and repair mechanisms. Based upon this foundational understanding, a critical evaluation was conducted to assess its impact on sleep-wake regulation. Current scientific evidence from both preclinical and clinical research suggests that PBM has the potential to influence sleep architecture, duration, and quality through complex interactions with cellular metabolic pathways and neurophysiological mechanisms governing the sleep-wake cycle. Despite growing scientific interest, significant research gaps persist; elucidating the precise cellular and molecular mechanisms by which PBM affects sleep physiology remains a primary challenge. There is an urgent need to standardize intervention protocols, including determining optimal wavelengths, dosage parameters, treatment durations, and delivery methods, to ensure consistent and reproducible results. Future research should focus on identifying predictive biomarkers for personalized treatment, examining transcranial PBM’s effects on neural pathways involved in sleep regulation, and assessing long-term safety to address potential cumulative effects. In conclusion, while PBM shows promise as a non-invasive therapeutic approach for sleep regulation, rigorous research is needed to establish its clinical efficacy and understand its molecular mechanisms, ultimately advancing it from an experimental therapy to a standardized treatment for sleep disorders.
... Gamma stimulation therapy might have considerably fewer side effects than pharmacological interventions 56,57 , and may be a supplement to pharmacological therapy. Various 40 Hz stimulation methods exist, such as sensory stimulation (tactile 58 , visual 51,59 , auditory 60 , or a combination 61 ), transcranial magnetic stimulation (TMS) 55 , transcranial alternating current stimulation (tACS) 62,63 , and Transcranial photobiomodulation (tPBM) 64 . Each method has distinct advantages and disadvantages impacting both efficacy and usability. ...
Article
Full-text available
Light-based gamma entrainment using sensory stimuli (GENUS) shows considerable potential for the treatment of Alzheimer’s disease (AD) in both animal and human models. While the clinical efficacy of GENUS for AD is paramount, its effectiveness will eventually also rely on the barrier to treatment adherence imposed by the discomfort of gazing at luminance flickering (LF) light. Currently, there have been few attempts to improve the comfort of GENUS. Here we investigate if Invisible spectral flicker (ISF), a novel type of light-based 40 Hz GENUS for which the flicker is almost imperceptible, can be used as a more comfortable option. We found that whereas ISF, LF, and chromatic flicker (CF) all produce a 40 Hz steady-state visually evoked potential (SSVEP), ISF scores significantly better on measures of comfort and perceived flicker. We also demonstrate that, while there is a trend towards a lower SSVEP response, reducing the stimulation brightness has no significant effect on the 40 Hz SSVEP or perceived flicker, though it significantly improves comfort. Finally, there is a slight decrease in the 40 Hz SSVEP response when stimulating with ISF from increasingly peripheral angles. This may ease the discomfort of GENUS treatment by freeing patients from gazing directly at the light. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-024-75448-4.
Article
Unlabelled: The aim of the study was to investigate the effect of photobiomodulation therapy (PBMT) on the amount of p53 in neurons of the pyramidal layer of the hippocampus after modeling septoplasty in rats. Materials and methods: Septoplasty was modeled in 48 Wistar rats. PBMT was administered to 24 rats in the early postoperative period for 2 to 6 days. Histological sections of the hippocampus were studied to determine p53-positive neurons on days 2, 4, and 6 after surgery in rats of both groups. Results: Compared with the control group (n = 5 rats), in both experimental groups there was an increase in the number of p53-positive neurons in the hippocampus, however, in the group where PBMT was performed in the early postoperative period after modeling septoplasty, the number of such neurons was lower, and in some subfields of the hippocampus on day 6 it even corresponded to the control group. Conclusions: The use of PBMT in the early postoperative period after modeling septoplasty helps to reduce stress-induced expression of the p53 protein in the pyramidal layer of the hippocampus in rats.
Article
Photopharmacology is an innovative approach that uses light to activate drugs. This method offers the potential for highly localized and precise drug activation, making it particularly promising for the treatment of neurological disorders. Despite the enticing prospects of photopharmacology, its application to treat human central nervous system (CNS) diseases remains to be demonstrated. In this review, we provide an overview of prominent strategies for the design and activation of photopharmaceutical agents in the field of neuroscience. Photocaged and photoswitchable drugs and bioactive molecules are discussed, and an instructive list of examples is provided to highlight compound design strategies. Special emphasis is placed on photoactivatable compounds for the modulation of glutamatergic, GABAergic, dopaminergic, and serotonergic neurotransmission for the treatment of neurological conditions, as well as various photoresponsive molecules with potential for improved pain management. Compounds holding promise for clinical translation are discussed in‐depth and their potential for future applications is assessed. Neurophotopharmaceuticals have yet to achieve breakthrough in the clinic, as both light delivery and drug design have not reached full maturity. However, by describing the current state of the art and providing illustrative case studies, we offer a perspective on future opportunities in the field of neurophotopharmacology focused on addressing CNS disorders.
Article
Significance Transcranial photobiomodulation (tPBM) is an optical intervention that effectively enhances human cognition. However, limited studies have reported the effects of tPBM on electrophysiological brain networks. Aim We aimed to investigate the site- and electroencephalogram (EEG)-frequency–specific effects of 800-nm prefrontal tPBM on the EEG global network topology of the human brain, so a better understanding of how tPBM alters EEG brain networks can be achieved. Approach A total of 26 healthy young adults participated in the study, with multiple visits when either active or sham tPBM interventions were delivered to either the left or right forehead. A 19-channel EEG cap recorded the time series before and after the 8-min tPBM/sham. We used graph theory analysis (GTA) and formulated adjacency matrices in five frequency bands, followed by quantification of normalized changes in GTA-based global topographical metrics induced by the respective left and right tPBM/sham interventions. Results Statistical analysis indicated that the effects of 800-nm prefrontal tPBM on the EEG global topological networks are both site- and EEG-frequency–dependent. Specifically, our results demonstrated that the left 800-nm tPBM primarily enhanced the alpha network efficiency and information transmission, whereas the right 800-nm tPBM augmented the clustering ability of the EEG topological networks and improved the formation of small-worldness of the beta waves across the entire brain. Conclusions The study concluded that 800-nm prefrontal tPBM can enhance global connectivity patterns and information transmission in the human brain, with effects that are site- and EEG-frequency–specific. To further confirm and better understand these findings, future research should correlate post-tPBM cognitive assessments with EEG network analysis.
Article
Full-text available
Brains are highly metabolic organs that emit ultraweak photon emissions (UPEs), which predict oxidative stress, aging, and neurodegeneration. UPEs are triggered by neurotransmitters and biophysical stimuli, but they are also generated by cells at rest and can be passively recorded using modern photodetectors in dark environments. UPEs play a role in cell-to-cell communication, and neural cells might even have waveguiding properties that support optical channels. However, it remains uncertain whether passive light emissions can be used to infer brain states as electric and magnetic fields do for encephalography. We present evidence that brain UPEs differ from background light in spectral and entropic properties, respond dynamically to tasks and stimulation, and correlate moderately with brain rhythms. We discuss these findings in the context of other neuroimaging methods, the potential of new measurement parameters, the limitations of light-based readouts, and the possibility of developing a platform to readout functional brain states: photoencephalography.
Article
Full-text available
Gamma oscillations in brain activity (30–150 Hz) have been studied for over 80 years. Although in the past three decades significant progress has been made to try to understand their functional role, a definitive answer regarding their causal implication in perception, cognition, and behavior still lies ahead of us. Here, we first review the basic neural mechanisms that give rise to gamma oscillations and then focus on two main pillars of exploration. The first pillar examines the major theories regarding their functional role in information processing in the brain, also highlighting critical viewpoints. The second pillar reviews a novel research direction that proposes a therapeutic role for gamma oscillations, namely the gamma entrainment using sensory stimulation (GENUS). We extensively discuss both the positive findings and the issues regarding reproducibility of GENUS. Going beyond the functional and therapeutic role of gamma, we propose a third pillar of exploration, where gamma, generated endogenously by cortical circuits, is essential for maintenance of healthy circuit function. We propose that four classes of interneurons, namely those expressing parvalbumin (PV), vasointestinal peptide (VIP), somatostatin (SST), and nitric oxide synthase (NOS) take advantage of endogenous gamma to perform active vasomotor control that maintains homeostasis in the neuronal tissue. According to this hypothesis, which we call GAMER (GAmma MEdiated ciRcuit maintenance), gamma oscillations act as a ‘servicing’ rhythm that enables efficient translation of neural activity into vascular responses that are essential for optimal neurometabolic processes. GAMER is an extension of GENUS, where endogenous rather than entrained gamma plays a fundamental role. Finally, we propose several critical experiments to test the GAMER hypothesis.
Article
Full-text available
Objective: To examine the effects of transcranial and intranasal photobiomodulation (PBM) therapy, administered at home, in patients with dementia. Background: This study sought to replicate and build upon a previously published case series report describing improved cognitive function in five patients with mild-to-moderate dementia after 12 weeks of transcranial and intranasal near-infrared (NIR) PBM therapy. Materials and methods: Eight participants (mean age: 79.8 ± 5.8 years old) diagnosed with dementia by their physicians were randomized to 12 weeks of usual care (UC, n = 4) or home PBM treatments (n = 4). The NIR PBM treatments were administered by a study partner at home three times per week with the Vielight Neuro Gamma device. The participants were assessed with the Alzheimer's Disease Assessment Scale-cognitive (ADAS-cog) subscale and the Neuropsychiatric Inventory (NPI) at baseline and 6 and 12 weeks, and with arterial spin-labeled perfusion magnetic resonance imaging (MRI) and resting-state functional MRI at baseline and 12 weeks. Results: At baseline, the UC and PBM groups did not differ demographically or clinically. However, after 12 weeks, there were improvements in ADAS-cog (group × time interaction: F1,6 = 16.35, p = 0.007) and NPI (group × time interaction: F1,6 = 7.52, p = 0.03), increased cerebral perfusion (group × time interaction: F1,6 = 8.46, p < 0.03), and increased connectivity between the posterior cingulate cortex and lateral parietal nodes within the default-mode network in the PBM group. Conclusions: Because PBM was well tolerated and associated with no adverse side effects, these results support the potential of PBM therapy as a viable home treatment for individuals with dementia.
Article
Full-text available
Brain photobiomodulation (PBM) therapy using red to near-infrared (NIR) light is an innovative treatment for a wide range of neurological and psychological conditions. Red/NIR light is able to stimulate complex IV of the mitochondrial respiratory chain (cytochrome c oxidase) and increase ATP synthesis. Moreover, light absorption by ion channels results in release of Ca²⁺ and leads to activation of transcription factors and gene expression. Brain PBM therapy enhances the metabolic capacity of neurons and stimulates anti-inflammatory, anti-apoptotic, and antioxidant responses, as well as neurogenesis and synaptogenesis. Its therapeutic role in disorders such as dementia and Parkinson’s disease, as well as to treat stroke, brain trauma, and depression has gained increasing interest. In the transcranial PBM approach, delivering a sufficient dose to achieve optimal stimulation is challenging due to exponential attenuation of light penetration in tissue. Alternative approaches such as intracranial and intranasal light delivery methods have been suggested to overcome this limitation. This article reviews the state-of-the-art preclinical and clinical evidence regarding the efficacy of brain PBM therapy.
Article
Full-text available
Photobiomodulation (PBM) also known as low-level level laser therapy is the use of red and near-infrared light to stimulate healing, relieve pain, and reduce inflammation. The primary chromophores have been identified as cytochrome c oxidase in mitochondria, and calcium ion channels (possibly mediated by light absorption by opsins). Secondary effects of photon absorption include increases in ATP, a brief burst of reactive oxygen species, an increase in nitric oxide, and modulation of calcium levels. Tertiary effects include activation of a wide range of transcription factors leading to improved cell survival, increased proliferation and migration, and new protein synthesis. There is a pronounced biphasic dose response whereby low levels of light have stimulating effects, while high levels of light have inhibitory effects. It has been found that PBM can produce ROS in normal cells, but when used in oxidatively stressed cells or in animal models of disease, ROS levels are lowered. PBM is able to up-regulate anti-oxidant defenses and reduce oxidative stress. It was shown that PBM can activate NF-kB in normal quiescent cells, however in activated inflammatory cells, inflammatory markers were decreased. One of the most reproducible effects of PBM is an overall reduction in inflammation, which is particularly important for disorders of the joints, traumatic injuries, lung disorders, and in the brain. PBM has been shown to reduce markers of M1 phenotype in activated macrophages. Many reports have shown reductions in reactive nitrogen species and prostaglandins in various animal models. PBM can reduce inflammation in the brain, abdominal fat, wounds, lungs, spinal cord.
Article
Full-text available
The US Air Force Office of Scientific Research convened a meeting of researchers in the fields of neuroscience, psychology, engineering, and medicine to discuss most pressing issues facing ongoing research in the field of transcranial direct current stimulation (tDCS) and related techniques. In this study, we present opinions prepared by participants of the meeting, focusing on the most promising areas of research, immediate and future goals for the field, and the potential for hormesis theory to inform tDCS research. Scientific, medical, and ethical considerations support the ongoing testing of tDCS in healthy and clinical populations, provided best protocols are used to maximize safety. Notwithstanding the need for ongoing research, promising applications include enhancing vigilance/attention in healthy volunteers, which can accelerate training and support learning. Commonly, tDCS is used as an adjunct to training/rehabilitation tasks with the goal of leftward shift in the learning/treatment effect curves. Although trials are encouraging, elucidating the basic mechanisms of tDCS will accelerate validation and adoption. To this end, biomarkers (eg, clinical neuroimaging and findings from animal models) can support hypotheses linking neurobiological mechanisms and behavioral effects. Dosage can be optimized using computational models of current flow and understanding dose–response. Both biomarkers and dosimetry should guide individualized interventions with the goal of reducing variability. Insights from other applied energy domains, including ionizing radiation, transcranial magnetic stimulation, and low-level laser (light) therapy, can be prudently leveraged.
Article
Full-text available
Objective: This study investigated whether patients with mild to moderately severe dementia or possible Alzheimer's disease (AD) with Mini-Mental State Exam (MMSE) Baseline scores of 10-24 would improve when treated with near-infrared photobiomodulation (PBM) therapy. Background: Animal studies have presented the potential of PBM for AD. Dysregulation of the brain's default mode network (DMN) has been associated with AD, presenting the DMN as an identifiable target for PBM. Materials and methods: The study used 810 nm, 10 Hz pulsed, light-emitting diode devices combining transcranial plus intranasal PBM to treat the cortical nodes of the DMN (bilateral mesial prefrontal cortex, precuneus/posterior cingulate cortex, angular gyrus, and hippocampus). Five patients with mild to moderately severe cognitive impairment were entered into 12 weeks of active treatment as well as a follow-up no-treatment, 4-week period. Patients were assessed with the MMSE and Alzheimer's Disease Assessment Scale (ADAS-cog) tests. The protocol involved weekly, in-clinic use of a transcranial-intranasal PBM device; and daily at-home use of an intranasal-only device. Results: There was significant improvement after 12 weeks of PBM (MMSE, p < 0.003; ADAS-cog, p < 0.023). Increased function, better sleep, fewer angry outbursts, less anxiety, and wandering were reported post-PBM. There were no negative side effects. Precipitous declines were observed during the follow-up no-treatment, 4-week period. This is the first completed PBM case series to report significant, cognitive improvement in mild to moderately severe dementia and possible AD cases. Conclusions: Results suggest that larger, controlled studies are warranted. PBM shows potential for home treatment of patients with dementia and AD.
Article
Full-text available
Sharp wave-ripple (SWR) oscillations play a key role in memory consolidation during non-rapid eye movement sleep, immobility, and consummatory behavior. However, whether temporally modulated synaptic excitation or inhibition underlies the ripples is controversial. To address this question, we performed simultaneous recordings of excitatory and inhibitory postsynaptic currents (EPSCs and IPSCs) and local field potentials (LFPs) in the CA1 region of awake mice in vivo. During SWRs, inhibition dominated over excitation, with a peak conductance ratio of 4.1 ± 0.5. Furthermore, the amplitude of SWR-associated IPSCs was positively correlated with SWR magnitude, whereas that of EPSCs was not. Finally, phase analysis indicated that IPSCs were phase-locked to individual ripple cycles, whereas EPSCs were uniformly distributed in phase space. Optogenetic inhibition indicated that PV⁺ interneurons provided a major contribution to SWR-associated IPSCs. Thus, phasic inhibition, but not excitation, shapes SWR oscillations in the hippocampal CA1 region in vivo.
Article
Full-text available
Changes in gamma oscillations (20–50 Hz) have been observed in several neurological disorders. However, the relationship between gamma oscillations and cellular pathologies is unclear. Here we show reduced, behaviourally driven gamma oscillations before the onset of plaque formation or cognitive decline in a mouse model of Alzheimer’s disease. Optogenetically driving fast-spiking parvalbumin-positive (FS-PV)-interneurons at gamma (40 Hz), but not other frequencies, reduces levels of amyloid-β (Aβ)1–40 and Aβ 1–42 isoforms. Gene expression profiling revealed induction of genes associated with morphological transformation of microglia, and histological analysis confirmed increased microglia co-localization with Aβ. Subsequently, we designed a non-invasive 40 Hz light-flickering regime that reduced Aβ1–40 and Aβ1–42 levels in the visual cortex of pre-depositing mice and mitigated plaque load in aged, depositing mice. Our findings uncover a previously unappreciated function of gamma rhythms in recruiting both neuronal and glial responses to attenuate Alzheimer’s-disease-associated pathology.
Article
Recent work has indicated that photobiomodulation (PBM) may beneficially alter the pathological status of several neurological disorders, although the mechanism currently remains unclear. The current study was designed to investigate the beneficial effect of PBM on behavioral deficits and neurogenesis in a photothrombotic (PT) model of ischemic stroke in rats. From day 1 to day 7 after the establishment of PT model, 2-minute daily PBM (CW, 808nm, 350mW/cm(2), total 294J at scalp level) was applied on the infarct injury area (1.8mm anterior to the bregma and 2.5mm lateral from the midline). Rats received intraperitoneal injections of 5-bromodeoxyuridine (BrdU) twice daily (50mg/kg) from day 2 to 8 post-stoke, and samples were collected at day 14. We demonstrated that PBM significantly attenuated behavioral deficits and infarct volume induced by PT stroke. Further investigation displayed that PBM remarkably enhanced neurogenesis and synaptogenesis, as evidenced by immunostaining of BrdU, Ki67, DCX, MAP2, spinophilin, and synaptophysin. Mechanistic studies suggested beneficial effects of PBM were accompanied by robust suppression of reactive gliosis and the production of pro-inflammatory cytokines. On the contrary, the release of anti-inflammatory cytokines, cytochrome c oxidase activity and ATP production in peri-infarct regions were elevated following PBM treatment. Intriguingly, PBM could effectively switch an M1 microglial phenotype to an anti-inflammatory M2 phenotype. Our novel findings indicated that PBM is capable of promoting neurogenesis after ischemic stroke. The underlying mechanisms may rely on: 1) promotion of proliferation and differentiation of internal neuroprogenitor cells in the peri-infarct zone; 2) improvement of the neuronal microenvironment by altering inflammatory status and promoting mitochondrial function. These findings provide strong support for the promising therapeutic effect of PBM on neuronal repair following ischemic stroke.
Article
Purpose: Reports of the relationship between the default mode network (DMN) and alpha power are conflicting. Our goal was to assess this relationship by analyzing concurrently obtained EEG/functional MRI data using hypothesis-independent methods. Methods: We collected functional MRI and EEG data during eyes-closed rest in 20 participants aged 19 to 37 (10 females) and performed independent component analysis on the functional MRI data and a Hamming-windowed fast Fourier transform on the EEG data. We correlated functional MRI fluctuations in the DMN with alpha power. Results: Of the six independent components found to have significant relationships with alpha, four contained DMN-associated regions: One independent component was positively correlated with alpha power, whereas all others were negatively correlated. Furthermore, two independent components with opposite relationships with alpha had overlapping voxels in the medial prefrontal cortex and posterior cingulate cortex, suggesting that subpopulations of neurons within these classic nodes within the DMN may have different relationships to alpha power. Conclusions: Different parts of the DMN exhibit divergent relationships to alpha power. Our results highlight the relationship between DMN activity and alpha power, indicating that networks, such as the DMN, may have subcomponents that exhibit different behaviors.